These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 31541883)
41. Receptor⁻Receptor Interactions in Multiple 5-HT1A Heteroreceptor Complexes in Raphe-Hippocampal 5-HT Transmission and Their Relevance for Depression and Its Treatment. Borroto-Escuela DO; Narváez M; Ambrogini P; Ferraro L; Brito I; Romero-Fernandez W; Andrade-Talavera Y; Flores-Burgess A; Millon C; Gago B; Narvaez JA; Odagaki Y; Palkovits M; Diaz-Cabiale Z; Fuxe K Molecules; 2018 Jun; 23(6):. PubMed ID: 29865267 [TBL] [Abstract][Full Text] [Related]
42. In vivo occupancy of the 5-HT1A receptor by a novel pan 5-HT1(A/B/D) receptor antagonist, GSK588045, using positron emission tomography. Comley RA; van der Aart J; Gulyás B; Garnier M; Iavarone L; Halldin C; Rabiner EA Neuropharmacology; 2015 May; 92():44-8. PubMed ID: 25476970 [TBL] [Abstract][Full Text] [Related]
43. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism. du Jardin KG; Jensen JB; Sanchez C; Pehrson AL Eur Neuropsychopharmacol; 2014 Jan; 24(1):160-71. PubMed ID: 23916504 [TBL] [Abstract][Full Text] [Related]
44. Enhancement of the FGFR1 signaling in the FGFR1-5-HT1A heteroreceptor complex in midbrain raphe 5-HT neuron systems. Relevance for neuroplasticity and depression. Borroto-Escuela DO; Pérez-Alea M; Narvaez M; Tarakanov AO; Mudó G; Jiménez-Beristain A; Agnati LF; Ciruela F; Belluardo N; Fuxe K Biochem Biophys Res Commun; 2015 Jul; 463(3):180-6. PubMed ID: 25957476 [TBL] [Abstract][Full Text] [Related]
45. Serotonin 5-HT4 receptors: A new strategy for developing fast acting antidepressants? Vidal R; Castro E; Pilar-Cuéllar F; Pascual-Brazo J; Díaz A; Rojo ML; Linge R; Martín A; Valdizán EM; Pazos A Curr Pharm Des; 2014; 20(23):3751-62. PubMed ID: 24180399 [TBL] [Abstract][Full Text] [Related]
46. Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study. Watanabe A; Hasegawa S; Nishi K; Nguyen KQ; Diksic M Brain Res Bull; 2006 Mar; 69(2):101-8. PubMed ID: 16533657 [TBL] [Abstract][Full Text] [Related]
47. Agonist and antagonist bind differently to 5-HT1A receptors during Alzheimer's disease: A post-mortem study with PET radiopharmaceuticals. Vidal B; Sebti J; Verdurand M; Fieux S; Billard T; Streichenberger N; Troakes C; Newman-Tancredi A; Zimmer L Neuropharmacology; 2016 Oct; 109():88-95. PubMed ID: 27183968 [TBL] [Abstract][Full Text] [Related]
48. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies. Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925 [TBL] [Abstract][Full Text] [Related]
49. Targeting Serotonin1A Receptors for Treating Chronic Pain and Depression. Haleem DJ Curr Neuropharmacol; 2019; 17(12):1098-1108. PubMed ID: 31418663 [TBL] [Abstract][Full Text] [Related]
50. Effects of the Serotonin 5-HT Newman-Tancredi A; Varney MA; McCreary AC Neurochem Res; 2018 May; 43(5):1035-1046. PubMed ID: 29572645 [TBL] [Abstract][Full Text] [Related]
51. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior. Popova NK; Naumenko VS; Cybko AS; Bazovkina DV Neuroscience; 2010 Aug; 169(1):229-35. PubMed ID: 20423722 [TBL] [Abstract][Full Text] [Related]
52. 3D-QSAR study indicates an enhancing effect of membrane ions on psychiatric drugs targeting serotonin receptor 5-HT1A. Avram S; Milac AL; Mihailescu D Mol Biosyst; 2012 Apr; 8(5):1418-25. PubMed ID: 22373544 [TBL] [Abstract][Full Text] [Related]
53. Effects of acute and sustained administration of vortioxetine on the serotonin system in the hippocampus: electrophysiological studies in the rat brain. El Mansari M; Lecours M; Blier P Psychopharmacology (Berl); 2015 Jul; 232(13):2343-52. PubMed ID: 25665528 [TBL] [Abstract][Full Text] [Related]
55. Differential role of 5-HT1A and 5-HT1B receptors on the antinociceptive and antidepressant effect of tramadol in mice. Berrocoso E; Rojas-Corrales MO; Mico JA Psychopharmacology (Berl); 2006 Sep; 188(1):111-8. PubMed ID: 16832657 [TBL] [Abstract][Full Text] [Related]
56. Behavioral studies of serotonin receptor agonists as antidepressant drugs. Lucki I J Clin Psychiatry; 1991 Dec; 52 Suppl():24-31. PubMed ID: 1684363 [TBL] [Abstract][Full Text] [Related]
57. NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat. Iderberg H; McCreary AC; Varney MA; Kleven MS; Koek W; Bardin L; Depoortère R; Cenci MA; Newman-Tancredi A Exp Neurol; 2015 Sep; 271():335-50. PubMed ID: 26037043 [TBL] [Abstract][Full Text] [Related]
58. Serotonin 1A and Serotonin 4 Receptors: Essential Mediators of the Neurogenic and Behavioral Actions of Antidepressants. Samuels BA; Mendez-David I; Faye C; David SA; Pierz KA; Gardier AM; Hen R; David DJ Neuroscientist; 2016 Feb; 22(1):26-45. PubMed ID: 25488850 [TBL] [Abstract][Full Text] [Related]
59. Antidepressant-like effects of neferine in the forced swimming test involve the serotonin1A (5-HT1A) receptor in mice. Sugimoto Y; Furutani S; Nishimura K; Itoh A; Tanahashi T; Nakajima H; Oshiro H; Sun S; Yamada J Eur J Pharmacol; 2010 May; 634(1-3):62-7. PubMed ID: 20176013 [TBL] [Abstract][Full Text] [Related]